无陪护模式下医院感染防控体系的构建与应用效果

Construction and application effect of hospital-associated infection prevention and control system in a no-companion mode

  • 摘要:
    目的 构建适用于无陪护管理模式的医院感染防控体系,并通过实证研究评价其临床应用效果,为提升医疗安全提供参考。
    方法 系统构建以“流程标准化、人员专业化、环境结构化、监管闭环化”为核心的无陪护医院感染防控体系。选取厦门大学附属心血管病医院2016-2024年住院患者作为研究对象,将2016-2019年(传统陪护模式)设为对照组,2020-2024年(实施无陪护模式及新建防控体系)设为试验组。对比分析两组在医院感染例次率、特定多重耐药菌感染发现率、“三管”(中央导管、导尿管、呼吸机)相关感染发病率、医院感染现患率、环境卫生监测合格率、手卫生依从率等关键指标方面的差异。
    结果 试验组的医院感染例次率、医院感染现患率分别为1.43%和2.71%,均低于对照组(P<0.05);特定多重耐药菌感染发现率总体呈下降趋势:耐甲氧西林金黄色葡萄球菌(MRSA)感染发现率为0.02%、耐碳青霉烯类肺炎克雷伯菌感染发现率为0.03%、耐碳青霉烯类铜绿假单胞菌感染发现率为0.01%、耐万古霉素屎肠球菌感染发现率为0、耐碳青霉烯类鲍曼不动杆菌感染发现率为0.01%,低于对照组(P<0.05)。“三管”相关感染发病率均下降:呼吸机相关性肺炎、中央血管导管相关血流感染、导尿管相关尿路感染感染率为3.88‰、0.12‰、0.86‰,均低于对照组(P<0.05)。而手卫生依从率与环境卫生学监测合格率分别为82.57%和94.36%,均高于对照组(P<0.05)。
    结论  本研究构建的无陪护医院感染防控体系在实践中证实有效,能显著降低医院感染风险。该体系具备系统性与可操作性,为同类医疗机构推行无陪护管理模式提供了完整的实践范式与理论支持。

     

    Abstract:
    OBJECTIVE  To establish a hospital-associated infection prevention and control system for use in a no-companion management mode, and to evaluate its application effect, thereby providing a reference for improving medical safety.
    METHODS  A hospital-associated infection prevention and control system was developed for the no-companion mode, featuring standardized workflows, specialized personnel, a structured environment, and closed-loop supervision. Patients admitted to Xiamen Cardiovascular Hospital Xiamen University between 2016 and 2024 were enrolled in this study. Those admitted between 2016 and 2019 (traditional companion mode) served as the control group, while those admitted between 2020 and 2024 (no-companion mode with the newly implemented prevention and control system) served as the experimental group. The two groups were compared regarding key indicators, including the hospital-associated infection episode rate, prevalence rate of specific multidrug-resistant organism (MDRO) infections, incidence of "three-catheter" (central venous catheter, urinary catheter and ventilator)-associated infections, hospital-associated infection prevalence rate, environmental hygiene monitoring compliance rate and hand hygiene adherence rate.
    RESULTS  The experimental group showed a lower hospital-associated infection episode rate (1.43%) and prevalence rate (2.71%) compared with the control group (P<0.05). The detection rates of specific MDRO infections exhibited an overall downward trend: methicillin-resistant Staphylococcus aureus (MRSA) (0.02%), carbapenem-resistant Klebsiella pneumoniae (0.03%), carbapenem-resistant Pseudomonas aeruginosa (0.01%), vancomycin-resistant Enterococcus faecium (0%) and carbapenem-resistant Acinetobacter baumannii (0.01%), all lower than those in the control group (P<0.05). The incidence rates of "three-catheter"-associated infections decreased: ventilator-associated pneumonia (VAP, 3.88‰), central line-associated bloodstream infection (CLABSI, 0.12‰) and catheter-associated urinary tract infection (CAUTI, 0.86‰), all lower than those in the control group (P<0.05). Meanwhile, the hand hygiene adherence rate and environmental hygiene monitoring compliance rate were 82.57% and 94.36%, respectively, both higher than those in the control group (P<0.05).
    CONCLUSIONS  The hospital-associated infection prevention and control system developed for the no-companion mode is effective in clinical practice, significantly reducing the risk of hospital-associated infections. This systematic and practical framework offers a replicable model and theoretical basis for similar healthcare institutions adopting the no-companion management mode.

     

/

返回文章
返回